ArticleBMC biomedical engineering2025

FROP-1 peptide-conjugated ultrasmall superparamagnetic nanoparticles as a targeted T1-weighted MR contrast agent for breast cancer: in vitro study.

Melika Samari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.